360 related articles for article (PubMed ID: 28219702)
21. Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer.
Godel M; Ortone G; Anobile DP; Pasino M; Randazzo G; Riganti C; Kopecka J
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065551
[TBL] [Abstract][Full Text] [Related]
22. Emerging roles of hypoxia-inducible factors and reactive oxygen species in cancer and pluripotent stem cells.
Saito S; Lin YC; Tsai MH; Lin CS; Murayama Y; Sato R; Yokoyama KK
Kaohsiung J Med Sci; 2015 Jun; 31(6):279-86. PubMed ID: 26043406
[TBL] [Abstract][Full Text] [Related]
23. Relevance of mitochondrial genetics and metabolism in cancer development.
Gasparre G; Porcelli AM; Lenaz G; Romeo G
Cold Spring Harb Perspect Biol; 2013 Feb; 5(2):. PubMed ID: 23378588
[TBL] [Abstract][Full Text] [Related]
24. The tricarboxylic acid cycle in L₃ Teladorsagia circumcincta: metabolism of acetyl CoA to succinyl CoA.
Simcock DC; Walker LR; Pedley KC; Simpson HV; Brown S
Exp Parasitol; 2011 May; 128(1):68-75. PubMed ID: 21320492
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations.
Hollinshead KE; Tennant DA
Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):272-85. PubMed ID: 27196610
[TBL] [Abstract][Full Text] [Related]
26. Cancer Cell Metabolism Featuring Nrf2.
Chatterjee P; Yadav M; Chauhan N; Huang Y; Luo Y
Curr Drug Discov Technol; 2020; 17(3):263-271. PubMed ID: 30207221
[TBL] [Abstract][Full Text] [Related]
27. Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents.
Corrado M; Scorrano L; Campello S
Oncotarget; 2016 Jul; 7(29):46692-46706. PubMed ID: 27083002
[TBL] [Abstract][Full Text] [Related]
28. A mitochondrial-like aconitase in the bacterium Bacteroides fragilis: implications for the evolution of the mitochondrial Krebs cycle.
Baughn AD; Malamy MH
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4662-7. PubMed ID: 11880608
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial metabolism and cancer.
Weinberg F; Chandel NS
Ann N Y Acad Sci; 2009 Oct; 1177():66-73. PubMed ID: 19845608
[TBL] [Abstract][Full Text] [Related]
30. Oncometabolites: Unconventional triggers of oncogenic signalling cascades.
Sciacovelli M; Frezza C
Free Radic Biol Med; 2016 Nov; 100():175-181. PubMed ID: 27117029
[TBL] [Abstract][Full Text] [Related]
31. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
Selak MA; Armour SM; MacKenzie ED; Boulahbel H; Watson DG; Mansfield KD; Pan Y; Simon MC; Thompson CB; Gottlieb E
Cancer Cell; 2005 Jan; 7(1):77-85. PubMed ID: 15652751
[TBL] [Abstract][Full Text] [Related]
32. Oncometabolites in Cancer: Current Understanding and Challenges.
Liu Y; Yang C
Cancer Res; 2021 Jun; 81(11):2820-2823. PubMed ID: 33762356
[TBL] [Abstract][Full Text] [Related]
33. Warburg tumours and the mechanisms of mitochondrial tumour suppressor genes. Barking up the right tree?
Bayley JP; Devilee P
Curr Opin Genet Dev; 2010 Jun; 20(3):324-9. PubMed ID: 20304625
[TBL] [Abstract][Full Text] [Related]
34. Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer.
Li C; He C; Xu Y; Xu H; Tang Y; Chavan H; Duan S; Artigues A; Forrest ML; Krishnamurthy P; Han S; Holzbeierlein JM; Li B
Prostate; 2019 May; 79(6):628-639. PubMed ID: 30663084
[TBL] [Abstract][Full Text] [Related]
35. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
36. Intermediates of Krebs cycle correct the depression of the whole body oxygen consumption and lethal cooling in barbiturate poisoning in rat.
Ivnitsky JJ; Schäfer TV; Malakhovsky VN; Rejniuk VL
Toxicology; 2004 Oct; 202(3):165-72. PubMed ID: 15337580
[TBL] [Abstract][Full Text] [Related]
37. Fumarates and Cancer.
Fuhler GM; Eppinga H; Peppelenbosch MP
Trends Mol Med; 2017 Jan; 23(1):3-5. PubMed ID: 27986420
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU.
Favaro E; Ramachandran A; McCormick R; Gee H; Blancher C; Crosby M; Devlin C; Blick C; Buffa F; Li JL; Vojnovic B; Pires das Neves R; Glazer P; Iborra F; Ivan M; Ragoussis J; Harris AL
PLoS One; 2010 Apr; 5(4):e10345. PubMed ID: 20436681
[TBL] [Abstract][Full Text] [Related]
39. Energy metabolism of the contagious equine metritis bacterium.
Lindmark DG; Jarroll EL; Timoney PJ; Shin SJ
Infect Immun; 1982 May; 36(2):531-4. PubMed ID: 7085071
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress and oxidative damage in carcinogenesis.
Klaunig JE; Kamendulis LM; Hocevar BA
Toxicol Pathol; 2010 Jan; 38(1):96-109. PubMed ID: 20019356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
